There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...

Boston Scientific (NYSE: BSX) announced today that NICE issued guidance supporting the use of pulsed field ablation (PFA) for treating AFib.